ATE173934T1 - Peptide, die infektionen mit menschlichem immunschwächevirus hemmen und deren anwendungsweisen - Google Patents

Peptide, die infektionen mit menschlichem immunschwächevirus hemmen und deren anwendungsweisen

Info

Publication number
ATE173934T1
ATE173934T1 AT91915038T AT91915038T ATE173934T1 AT E173934 T1 ATE173934 T1 AT E173934T1 AT 91915038 T AT91915038 T AT 91915038T AT 91915038 T AT91915038 T AT 91915038T AT E173934 T1 ATE173934 T1 AT E173934T1
Authority
AT
Austria
Prior art keywords
peptides
applications
virus infections
inhibit human
deficiency virus
Prior art date
Application number
AT91915038T
Other languages
English (en)
Inventor
Anders Vahlne
Bo Svennerholm
Lars Rymo
Stig Jeansson
Peter Horal
Original Assignee
Anders Vahlne
Bo Svennerholm
Lars Rymo
Stig Jeansson
Peter Horal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anders Vahlne, Bo Svennerholm, Lars Rymo, Stig Jeansson, Peter Horal filed Critical Anders Vahlne
Application granted granted Critical
Publication of ATE173934T1 publication Critical patent/ATE173934T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06165—Dipeptides with the first amino acid being heterocyclic and Pro-amino acid; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0804—Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806—Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT91915038T 1990-08-22 1991-08-20 Peptide, die infektionen mit menschlichem immunschwächevirus hemmen und deren anwendungsweisen ATE173934T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US57108090A 1990-08-22 1990-08-22

Publications (1)

Publication Number Publication Date
ATE173934T1 true ATE173934T1 (de) 1998-12-15

Family

ID=24282265

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91915038T ATE173934T1 (de) 1990-08-22 1991-08-20 Peptide, die infektionen mit menschlichem immunschwächevirus hemmen und deren anwendungsweisen

Country Status (17)

Country Link
EP (1) EP0545991B1 (de)
JP (1) JP3115596B2 (de)
KR (1) KR100220531B1 (de)
AT (1) ATE173934T1 (de)
AU (1) AU667290B2 (de)
BR (1) BR9106772A (de)
CA (1) CA2088788C (de)
DE (1) DE69130571T2 (de)
DK (1) DK0545991T3 (de)
ES (1) ES2128322T3 (de)
FI (1) FI930519A (de)
GR (1) GR3029523T3 (de)
HU (1) HUT63177A (de)
MC (1) MC2306A1 (de)
NO (1) NO930401L (de)
OA (1) OA10051A (de)
WO (1) WO1992003147A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007088099A2 (en) * 2006-01-13 2007-08-09 Oncoreg Ab Compounds for the treatment of ischemia and neurodegeneration
FR2925501B1 (fr) * 2007-12-21 2012-12-14 Vincience Peptide activateur de la synthese des aquaporines et composition cosmetique et/ou pharmaceutique le contenant
FR2925500B1 (fr) * 2007-12-21 2011-05-06 Vincience Peptide derive d'une proteine de la famille des aquaporines et composition cosmetique et/ou pharmaceutique le contenant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0245362B1 (de) * 1985-10-24 1994-06-29 Ronald C. Kennedy Synthetische peptide und deren verwendung zur diagnose und impfung für aids und arc
NL8702403A (nl) * 1987-10-09 1989-05-01 Stichting Centr Diergeneeskund Oligopeptiden en gebruik daarvan voor diagnostische en vaccinatiedoeleinden voor aids en arc.

Also Published As

Publication number Publication date
BR9106772A (pt) 1993-07-20
MC2306A1 (fr) 1993-09-27
NO930401D0 (no) 1993-02-05
DE69130571D1 (de) 1999-01-14
CA2088788A1 (en) 1992-02-23
DK0545991T3 (da) 1999-08-16
WO1992003147A1 (en) 1992-03-05
EP0545991A1 (de) 1993-06-16
JP3115596B2 (ja) 2000-12-11
FI930519A (fi) 1993-04-21
GR3029523T3 (en) 1999-06-30
CA2088788C (en) 2003-12-16
JPH06504035A (ja) 1994-05-12
HU9300456D0 (en) 1993-05-28
FI930519A0 (fi) 1993-02-05
AU8433291A (en) 1992-03-17
DE69130571T2 (de) 1999-06-17
OA10051A (en) 1996-10-14
HUT63177A (en) 1993-07-28
ES2128322T3 (es) 1999-05-16
EP0545991B1 (de) 1998-12-02
KR100220531B1 (ko) 1999-10-01
AU667290B2 (en) 1996-03-21
NO930401L (no) 1993-02-17

Similar Documents

Publication Publication Date Title
CY1106152T1 (el) Νεα ανοσογονα αντι-hiv (ανατοξινες), μεθοδοι παρασκευης και εφαρμογη στην προληψη και στην αγωγη του aids
TR199903053T2 (xx) Benzimidazol t�revleri.
DE69632256D1 (de) Antivirale proteine, dafür kodierende dna, und deren verwendung
RU94022480A (ru) Способ лечения гепатита, композиция, усиливающая ин виво инактивацию вируса гепатита с, препарат для лечения гепатита с
DE3880766D1 (de) Konjugate von interferon alpha mit immunglobulinen.
GB2255093A (en) Hiv-1 core protein fragments
DE69838986D1 (de) Polypeptide, deren herstellung und verwendung
DE69131200T2 (de) Herpes simplex virus vp16 impfstoffe
DE3684305D1 (de) Antivirales immunotherapeutisches mittel und dessen herstellung.
DE3785388D1 (de) Antivirale peptide und mittel zur behandlung von herpes.
CY1106615T1 (el) Μεθοδος επιταχυνσης αναρρωσης ενος τραυματος χρησιμοποιωντας συνθετικες ή φυσικες οντοτητες που προσομοιωνουν την αποπτωση
DE58909850D1 (de) Arzneimittel zur behandlung von krebs, aids und viruserkrankungen
TR199801289T2 (en) Terap�tik bile�ikler.
ATE173934T1 (de) Peptide, die infektionen mit menschlichem immunschwächevirus hemmen und deren anwendungsweisen
FI944561A0 (fi) HIV:tä neutraloivia monoklonaalisia yhdistelmähumaanivasta-aineita HIV-infektion ehkäisemiseksi ja hoitamiseksi
DE69004451D1 (de) Prophylaxe und Behandlung von Herpesvirus-Infektionen.
ATE109158T1 (de) Rubella-e1 und c peptide.
EP0323157A3 (de) Antivirale Verbindungen und Methoden
KR960700741A (ko) 인터페론치료에 대한 무응답자의 c형 간염 치료방법(method of treating hepatitis c in non-pesponders to interferon treatment)
IL112183A0 (en) Use of bradykinin antagonists for the preparation of medicaments for the treatment of virus diseases
EP1143981A4 (de) Behandlung und vorbeugung von hiv- und anderen virus infektionen
HRP20030701A2 (en) Natural antibodies active against hiv virus
FR2709062A1 (fr) Composition à base de plutonium pour la prévention et le traitement homéopathiques de l'infection par le V.I.H. (virus de l'immunodéficience humaine).
ES2119987T3 (es) Derivados monoaceticos de los peptidos leu-phe-ala y ala-leu-phe y su uso en la identificacion y la destruccion de celulas tumorales y celulas infectadas por virus.
SE9502926D0 (sv) Epitope specific B-cell anergy in HiV-infection: New HIV-1 peptides, diagnostic antigens to detect the anergy, their use, vaccines and medicaments to prevent and treat it

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner
EEIH Change in the person of patent owner
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee